Effect of a Novel Protein Ingredient Combined With Oral Nutritional Supplement on Appetite in Older Adults
NCT ID: NCT06478147
Last Updated: 2024-06-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
17 participants
INTERVENTIONAL
2023-12-02
2024-06-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of a Novel Protein Supplement on Appetite in Older Adults
NCT05871060
Adding Appetite Stimulants to an ONS in Older Adults
NCT06645184
Determination of In-vivo Plasma AA Appearance From Plant Protein Fibre Products
NCT05420142
Effects of Consuming Protein Shakes, Varying in Protein Source, on Appetite, Satiety and Energy Intake
NCT03132376
Metabolic and Appetite Responses to Altered Timing of Whey Protein Ingestion
NCT02658110
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
All participants undertake all three experimental conditions in a random order.
TREATMENT
DOUBLE
The participant is fully blinded, i.e. treatments will be served in generic containers for Oral Nutritional Supplement (unlabelled) and vanilla-flavoured.
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Oral Nutritional Supplement
125 mL of commercially available of Oral Nutritional Supplement, a liquid food product containing vitamins, minerals, protein, fats and carbohydrates. 125 mL of product provides 37.0 g of carbohydrates, 11.6 g of fats, 12.0 g of proteins, vitamins and minerals.
Oral Nutritional Supplement
Commercially available Oral Nutritional Supplement alone consumed 90 minutes prior to an ad libitum breakfast
Oral Nutritional Supplement + Whey Protein Hydrolysate
2,2 grams of whey protein hydrolysate dissolved in 125 mL of commercially available of Oral Nutritional Supplement
Oral Nutritional Supplement + Whey Protein Hydrolysate
Whey Protein Hydrolysate dissolved in an Oral Nutritional Supplement consumed 90 minutes prior to an ad libitum breakfast
Whey Protein Hydrolysate
2,2 grams of whey protein hydrolysate dissolved in 125 mL of water
Whey Protein Hydrolysate + still water
Whey Protein Hydrolysate dissolved in still water consumed 90 minutes prior to an ad libitum breakfast
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Oral Nutritional Supplement
Commercially available Oral Nutritional Supplement alone consumed 90 minutes prior to an ad libitum breakfast
Oral Nutritional Supplement + Whey Protein Hydrolysate
Whey Protein Hydrolysate dissolved in an Oral Nutritional Supplement consumed 90 minutes prior to an ad libitum breakfast
Whey Protein Hydrolysate + still water
Whey Protein Hydrolysate dissolved in still water consumed 90 minutes prior to an ad libitum breakfast
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 60+ years
* Poor appetite (Simplified Nutritional Appetite Questionnaire (SNAQ) score \</=14, answer a, b or c to Q.1 on SNAQ or answer b, c, or d to CES-D question regarding poor appetite in the past week)
* BMI 20-25kg/m2
Exclusion Criteria
* Other medical condition that would impact study participation and outcomes, as judged by the study investigator.
* Heavy smoker (\>10/day)
* Inability to come to study centre
* Currently participating in another intervention study
* Lacking informed consent
* Allergic to or unwilling to consume any of the study test foods
* Loss of taste or smell associated with COVID-19
* Unable to walk across a room
60 Years
120 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
FHI 360
OTHER
University College Dublin
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Katy Horner
Lecturer in Sport and Exercise Science
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University College Dublin
Dublin, Leinster, Ireland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
LS-22-64-Horner#2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.